Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 386748, "name": "Biofil Chemicals", "stock_name": "Biofil Chemicals", "full_name": "Biofil Chemicals & Pharmaceuticals Ltd", "name_url": "stocks-analysis/biofil-chemicals", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "31.77", "chg": 0.22, "chgp": "0.7%", "dir": 1, "prev_price": "31.55", "mcapval": "52.00 Cr", "mcap": "Micro Cap", "scripcode": 524396, "symbol": "BIOFILCHEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE829A01014", "curr_date": "May 22", "curr_time": "", "bse_nse_vol": "4.46 k", "exc_status": "Active", "traded_date": "May 22, 2026", "traded_date_str": "2026 05 22", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biofil-chemicals-386748-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "When is the next results date for Biofil Chemicals & Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-biofil-chemicals-pharmaceuticals-ltd-4007364", "imagepath": "", "date": "2026-05-22 23:19:36", "description": "The next results date for Biofil Chemicals & Pharmaceuticals Ltd is scheduled for 30 May 2026...." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3996247", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiofilChemicals_mojoScore_3996247.png", "date": "2026-05-18 08:10:03", "description": "Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 15 May 2026, reflecting deteriorating technical indicators and persistently weak financial fundamentals. The micro-cap pharmaceutical company’s stock has underperformed key benchmarks, prompting a reassessment across quality, valuation, financial trend, and technical parameters." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-3977452", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiofilChemicals_mojoScore_3977452.png", "date": "2026-05-06 10:11:00", "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-3956332", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiofilChemicals_mojoScore_3956332.png", "date": "2026-04-22 10:10:51", "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Biofil Chemicals Gains 14.91%: 2 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-gains-1491-2-key-factors-driving-the-weeks-rally-3943164", "imagepath": "", "date": "2026-04-11 17:11:26", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>6 Apr:</strong> Week opens at Rs.29.45</p>\n <p><strong>7 Apr:</strong> Stock hits upper circuit limit, closing at Rs.32.39 (+9.98%)</p>\n <p><strong>8 Apr:</strong> MarketsMOJO upgrades rating to Sell on improved technicals and valuation</p>\n <p><strong>10 Apr:</strong> Week closes at Rs.33.84 (+1.32%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.29.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.33.84</div><div class=\"s..." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Improved Technicals and Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-upgraded-to-sell-on-improved-technicals-and-valuation-3936580", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiofilChemicals_mojoScore_3936580.png", "date": "2026-04-08 08:15:01", "description": "Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement in technical indicators and valuation metrics despite ongoing fundamental challenges. The micro-cap pharmaceutical company’s recent price surge and valuation appeal have prompted this reassessment, though financial trends and quality scores remain subdued." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 9.98% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3935338", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiofilChemicals_stocks_hitting_upper_circuit_3935338.png", "date": "2026-04-07 10:00:16", "description": "At Rs 32.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 9.98% on 7 Apr 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-strong-sell-3930077", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiofilChemicals_mojoScore_3930077.png", "date": "2026-04-02 10:10:41", "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 16 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 April 2026, providing investors with the latest perspective on the company’s position." }, { "title": "Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-biofil-chemicals-pharmaceuticals-ltd-fallingrising-3926874", "imagepath": "", "date": "2026-03-31 01:36:49", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Market Performance</strong></p>\n<p>The stock has been under significant pressure in recent weeks, with a one-week loss of 11.20% compared to the Sensex’s modest decline of 1.03%. Over the past month, Biofil Chemicals has fallen 15.76%, underperforming the benchmark index’s 10.33% drop. Year-to-date, the stock has declined nearly 25%, substantially worse than the Sensex’s 15.57% fall. This downward trend extends over longer periods as well, with the stock losing 37.69% in the last year and 61.17% over five years, while the Sensex has gained 43.50% during the same five-year span.</p>\n<p>On 30-Mar, the stock opened with a gap down of 5.96% and continued to slide throughout the day, hitting an intraday low of ₹25.60, which is also its new 52-week low. The weighted aver..." } ], "total": 178, "sid": "386748", "stock_news_url": "https://www.marketsmojo.com/news/biofil-chemicals-pharmaceuticals-386748" }, "announcements": [ { "details": "Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Disclosure of Related Party Transactions for the half year ended 30th September 2019 pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.", "source": "NSE", "caption": "Biofil Chemicals & Pharmaceuticals Limited - Other General Purpose", "datetime": "03-Dec-2019" }, { "details": "Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Extracts of Financial Results for Quarter and half year ended 30th September, 2019 published in News Paper i.e. Free press Mumbai & Indore (in English) and Choutha Sansar (in Hindi) on 16th November, 2019.'.", "source": "NSE", "caption": "Biofil Chemicals & Pharmaceuticals Limited - Updates", "datetime": "18-Nov-2019" }, { "details": "Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of the SEBI(Listing Obligation and Disclosure Requirement) Regulations 2015, Please find enclosed public notice which was published on in Free Press, Indore and The Free Press Journal, Mumbai (in English) and Choutha Sansar, Indore (in hindi) for the upcoming Board Meeting scheduled on 14th November 2019.", "source": "NSE", "caption": "Biofil Chemicals & Pharmaceuticals Limited - Updates", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "30 May 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

6 Apr: Week opens at Rs.29.45

7 Apr: Stock hits upper circuit limit, closing at Rs.32.39 (+9.98%)

8 Apr: MarketsMOJO upgrades rating to Sell on improved technicals and valuation

10 Apr: Week closes at Rs.33.84 (+1.32%)

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Improved Technicals and Valuation

2026-04-08 08:15:01

Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement in technical indicators and valuation metrics despite ongoing fundamental challenges. The micro-cap pharmaceutical company’s recent price surge and valuation appeal have prompted this reassessment, though financial trends and quality scores remain subdued.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 9.98% Gain — Buyers Queue, Sellers Absent

2026-04-07 10:00:16

At Rs 32.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 9.98% on 7 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell

2026-04-02 10:10:41

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 16 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 April 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?

2026-03-31 01:36:49

Recent Price Movements and Market Performance

The stock has been under significant pressure in recent weeks, with a one-week loss of 11.20% compared to the Sensex’s modest decline of 1.03%. Over the past month, Biofil Chemicals has fallen 15.76%, underperforming the benchmark index’s 10.33% drop. Year-to-date, the stock has declined nearly 25%, substantially worse than the Sensex’s 15.57% fall. This downward trend extends over longer periods as well, with the stock losing 37.69% in the last year and 61.17% over five years, while the Sensex has gained 43.50% during the same five-year span.

On 30-Mar, the stock opened with a gap down of 5.96% and continued to slide throughout the day, hitting an intraday low of ₹25.60, which is also its new 52-week low. The weighted aver...

Read full news article

View All News